PATENT CLAIM ANALYSIS

Application Number: 16024558
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates a method wherein a molecule is used for inducing and/or promoting skipping of at least one of exon 43, exon 46, exons 50-53 of the DMD pre-mRNA in a patient, preferably in an isolated cell of a patient, the method comprising providing said cell and/or said patient with a molecule. The invention also relates to said molecule as such.

Claim (Index 12):
The isolated antisense oligonucleotide of  claim 1 , wherein said oligonucleotide comprises a backbone selected from a group consisting of: a morpholino backbone, a carbamate backbone, a siloxane backbone, a sulfide backbone, a sulfoxide backbone, a sulfone backbone, a formacetyl backbone, a thioformacetyl backbone, a methyleneformacetyl backbone, a riboacetyl backbone, an alkene containing backbone, a sulfamate backbone, a sulfonate backbone, a sulfonamide backbone, a methyleneimino backbone, a methylenehydrazino backbone and an amide backbone.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.61905
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15468239', '12605276', '12992218', '14248279', '15428385']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8021859085238686
- 35 USC 102 Novelty (BERT): 0.5346265953007048
- Combined Prediction Score: 0.7754299772015523
- Mean Citation Score: 367.672316
- Max Citation Score: 377.07214
- Similarity Product: 257.99646239704134

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test